Literature DB >> 10831475

Association between bipolar disorder and monoamine oxidase A gene polymorphisms: results of a multicenter study.

M Preisig1, F Bellivier, B T Fenton, P Baud, A Berney, P Courtet, P Hardy, J Golaz, M Leboyer, J Mallet, M L Matthey, D Mouthon, E Neidhart, M Nosten-Bertrand, E Stadelmann-Dubuis, J Guimon, F Ferrero, C Buresi, A Malafosse.   

Abstract

OBJECTIVE: Although genetic factors have been implicated in the etiology of bipolar disorder, no specific gene has been conclusively identified. Given the link between abnormalities in serotonergic neurotransmission and bipolar disorder, a candidate gene association approach was applied to study the involvement of the monoamine oxidase A (MAOA) gene, which codes for a catabolic enzyme of serotonin, in the susceptibility to bipolar disorder.
METHOD: In France and Switzerland, 272 patients with bipolar disorder and 122 healthy subjects were typed for three polymorphic markers of the MAOA gene: the MAOA-CA repeat, the MAOA restriction fragment length polymorphism (RFLP), and a repeat directly adjacent to the variable number of tandem repeats (VNTR) locus.
RESULTS: A significant difference in the distribution of the alleles for the MAOA-CA repeat was observed between the female bipolar patients and comparison group.
CONCLUSIONS: The results obtained in the French and Swiss population confirm findings from two studies conducted in the United Kingdom.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10831475     DOI: 10.1176/appi.ajp.157.6.948

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  18 in total

Review 1.  Review of bipolar molecular linkage and association studies.

Authors:  Wade Berrettini
Journal:  Curr Psychiatry Rep       Date:  2002-04       Impact factor: 5.285

2.  Genetics of major mood disorders.

Authors:  Wade Berrettini
Journal:  Psychiatry (Edgmont)       Date:  2004-09

3.  A linkage and family-based association analysis of a potential neurocognitive endophenotype of bipolar disorder.

Authors:  Jonathan Savitz; Lize van der Merwe; Mark Solms; Rajkumar Ramesar
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

4.  The influence of five monoamine genes on trajectories of depressive symptoms across adolescence and young adulthood.

Authors:  Daniel E Adkins; Jonathan K Daw; Joseph L McClay; Edwin J C G van den Oord
Journal:  Dev Psychopathol       Date:  2012-02

Review 5.  The genetics of schizophrenia and bipolar disorder: dissecting psychosis.

Authors:  N Craddock; M C O'Donovan; M J Owen
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

6.  Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder.

Authors:  Alessandro Serretti; Paola Artioli; Raffaella Zanardi; Cristina Lorenzi; David Rossini; Cristina Cusin; Alessia Arnoldi; Marco Catalano
Journal:  Psychopharmacology (Berl)       Date:  2004-07-10       Impact factor: 4.530

7.  MAOA Variants and Genetic Susceptibility to Major Psychiatric Disorders.

Authors:  Zichao Liu; Liang Huang; Xiong-Jian Luo; Lichuan Wu; Ming Li
Journal:  Mol Neurobiol       Date:  2015-07-31       Impact factor: 5.590

8.  Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene.

Authors:  Lea K Davis; Heather C Hazlett; Amy L Librant; Peggy Nopoulos; Val C Sheffield; Joesph Piven; Thomas H Wassink
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-10-05       Impact factor: 3.568

9.  Neither single-marker nor haplotype analyses support an association between monoamine oxidase A gene and bipolar disorder.

Authors:  San-Yuan Huang; Ming-Teng Lin; Mee-Jen Shy; Wei-Wen Lin; Fang-Yi Lin; Ru-Band Lu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04-24       Impact factor: 5.270

Review 10.  Brain-derived neurotrophic factor as a potential risk locus for bipolar disorder: evidence, limitations, and implications.

Authors:  Elaine Green; Nick Craddock
Journal:  Curr Psychiatry Rep       Date:  2003-12       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.